Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.

The Journal of pathology - 1 Sept 2007

Sahadevan K, Darby S, Leung H Y, Mathers M E, Robson C N, Gnanapragasam V J

Abstract excerpt

Fibroblast growth factor receptors (FGFRs) mediate the tumourigenic effects of FGFs in prostate cancer. These receptors are therefore potential therapeutic targets in the development of inhibitors to this pathway. To identify the most relevant targets, we simultaneously investigated FGFR1-4 expre...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Microdissection
Share to Microscopy, Confocal
Share to Receptor, Fibroblast Growth Factor, Type 1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Receptor, Fibroblast Growth Factor, Type 2

Share to Receptor, Fibroblast Growth Factor, Type 3

Share to Receptor, Fibroblast Growth Factor, Type 4

Share to Receptors, Fibroblast Growth Factor

Share to RNA, Small Interfering

Source

Identifiers

PMID: 17607666
DOI: 10.1002/path.2205

Genes

FGFR4
FGFR1
FGFR3
FGFR2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-17607666-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.PMID 17607666Read ↗

FGFR-4 Arg³⁸⁸ enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling.Semantic proximity Read ↗

Evidence for distinct alterations in the FGF axis in prostate cancer progression to an aggressive clinical phenotype.Semantic proximity Read ↗

The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression.Semantic proximity Read ↗

Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis.Semantic proximity Read ↗

Altered fibroblast growth factor receptor 4 stability promotes prostate cancer progression.Semantic proximity Read ↗

Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasionSemantic proximity Read ↗

Alternative splicing of fibroblast growth factor receptors in human prostate cancerSemantic proximity Read ↗

Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancerSemantic proximity Read ↗

Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.Semantic proximity Read ↗

FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.Semantic proximity Read ↗

TGFBR3 loss and consequences in prostate cancerSemantic proximity Read ↗

FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.